These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15053879)

  • 1. Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression.
    Li HH; Li AG; Sheppard HM; Liu X
    Mol Cell; 2004 Mar; 13(6):867-78. PubMed ID: 15053879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of a DNA damage checkpoint response in a TAF1-defective cell line.
    Buchmann AM; Skaar JR; DeCaprio JA
    Mol Cell Biol; 2004 Jun; 24(12):5332-9. PubMed ID: 15169897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response.
    Wu Y; Lin JC; Piluso LG; Dhahbi JM; Bobadilla S; Spindler SR; Liu X
    Mol Cell; 2014 Jan; 53(1):63-74. PubMed ID: 24289924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation-dependent regulation of cyclin D1 and cyclin A gene transcription by TFIID subunits TAF1 and TAF7.
    Kloet SL; Whiting JL; Gafken P; Ranish J; Wang EH
    Mol Cell Biol; 2012 Aug; 32(16):3358-69. PubMed ID: 22711989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding.
    Sakaguchi K; Saito S; Higashimoto Y; Roy S; Anderson CW; Appella E
    J Biol Chem; 2000 Mar; 275(13):9278-83. PubMed ID: 10734067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High glucose-induced p53 phosphorylation contributes to impairment of endothelial antioxidant system.
    Wu Y; Lee S; Bobadilla S; Duan SZ; Liu X
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2355-2362. PubMed ID: 28673515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2.
    Allende-Vega N; McKenzie L; Meek D
    Mol Cell Biochem; 2008 Sep; 316(1-2):99-106. PubMed ID: 18548200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage.
    Cai X; Liu X
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):16958-63. PubMed ID: 18952844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
    Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
    FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.
    Vega FM; Sevilla A; Lazo PA
    Mol Cell Biol; 2004 Dec; 24(23):10366-80. PubMed ID: 15542844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein.
    Lopez-Borges S; Lazo PA
    Oncogene; 2000 Jul; 19(32):3656-64. PubMed ID: 10951572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
    Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
    EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An acetylation switch in p53 mediates holo-TFIID recruitment.
    Li AG; Piluso LG; Cai X; Gadd BJ; Ladurner AG; Liu X
    Mol Cell; 2007 Nov; 28(3):408-21. PubMed ID: 17996705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53.
    Allende-Vega N; Saville MK; Meek DW
    Oncogene; 2007 Jun; 26(29):4234-42. PubMed ID: 17237821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.
    Chehab NH; Malikzay A; Appel M; Halazonetis TD
    Genes Dev; 2000 Feb; 14(3):278-88. PubMed ID: 10673500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of a TAF1-TAF7 complex in human transcription factor IID reveals a promoter binding module.
    Wang H; Curran EC; Hinds TR; Wang EH; Zheng N
    Cell Res; 2014 Dec; 24(12):1433-44. PubMed ID: 25412659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAF1 histone acetyltransferase activity in Sp1 activation of the cyclin D1 promoter.
    Hilton TL; Li Y; Dunphy EL; Wang EH
    Mol Cell Biol; 2005 May; 25(10):4321-32. PubMed ID: 15870300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cell cycle regulatory factor TAF1 stimulates ribosomal DNA transcription by binding to the activator UBF.
    Lin CY; Tuan J; Scalia P; Bui T; Comai L
    Curr Biol; 2002 Dec; 12(24):2142-6. PubMed ID: 12498690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Dual TAF1-ATR Inhibitors and Ligand-Induced Structural Changes of the TAF1 Tandem Bromodomain.
    Karim RM; Yang L; Chen L; Bikowitz MJ; Lu J; Grassie D; Shultz ZP; Lopchuk JM; Chen J; Schönbrunn E
    J Med Chem; 2022 Mar; 65(5):4182-4200. PubMed ID: 35191694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage-induced activation of p53 by the checkpoint kinase Chk2.
    Hirao A; Kong YY; Matsuoka S; Wakeham A; Ruland J; Yoshida H; Liu D; Elledge SJ; Mak TW
    Science; 2000 Mar; 287(5459):1824-7. PubMed ID: 10710310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.